About PeptideMap

What is PeptideMap?

PeptideMap is an evidence-based resource that aggregates peptide research from two complementary sources:

• 1. Peer-reviewed research - Clinical trials, preclinical studies, and review articles from PubMed/PMC
• 2. Community experiences - Real-world reports from online peptide communities

We believe the most useful peptide resource combines rigorous scientific data with practical user experiences.

Our Data

Methodology

What We Show

• • Research counts and key studies with study type labels (clinical trial, review, preclinical)
• • Community-reported outcomes, side effects, dosing patterns, stacks, and switching trends
• • Price ranges from research-grade vendors (US and China) with clear caveats

What We Don’t Show

• • Vendor names, links, or purchasing guidance
• • Medical advice or prescriptive dosing instructions
• • Identifying details from community posts

Confidence & Sample Size

Community data is aggregated from many posts and authors. We display exact counts where available, and label data as community-reported to distinguish it from clinical evidence.

Outcome Grades (A-D)

Outcomes are graded based on how frequently they're mentioned positively in community discussions:

• A Very commonly reported, consistent positive mentions
• B Frequently reported with generally positive outcomes
• C Moderately reported, mixed or variable results
• D Rarely reported or inconsistent results

Side Effect Frequency

Side effect percentages reflect how often each was mentioned among users who reported any side effects. This is community-reported data, not clinical trial data.

Risk Severity

• Serious - Potentially dangerous, requires immediate medical attention
• Warning - Important safety consideration, may require monitoring
• Caution - Should be aware of, usually manageable
• Common - Frequently reported, generally mild and expected

Pricing Data

Pricing is based on community-reported vendor prices at the time of data collection. Prices vary significantly by vendor, quantity, and time. Use as a rough reference only.

Research Indexing

We index research articles from PubMed/PMC and categorize them by study type. Key studies are selected to give a practical overview, not an exhaustive literature review.

Limitations

• • Community data reflects self-selected, often experienced users - not representative of general population
• • Self-reported outcomes are subject to placebo effects, recall bias, and selection bias
• • Dosing and source quality in community reports is highly variable
• • Research article selection is not exhaustive - we focus on key studies
• • Data may become outdated as new research emerges